Bright Peak Therapeutics Announces Formation of World Class Immuno-Oncology Scientific Advisory Board
SAN DIEGO & BASEL, Switzerland, Oct. 18 (Korea Bizwire) — Bright Peak Therapeutics, a privately held biotechnology company leveraging a revolutionary chemical protein engineering platform to develop next-generation multifunctional cytokine-based immunotherapies, today announced the formation of a Scientific Advisory Board (“SAB”) comprised of world-renowned experts in immuno-oncology basic, translational and clinical research. “Bright Peak is [...]